Afsheen Iqbal
Oncology
136 Mountainview Blvd
Basking Ridge, NJ 07920
Basking Ridge, NJ 07920
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non-Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 16, 2026
A Phase I Study of Cyclical Hypofractionated Palliative Radiotherapy (Quad Shot) for Central Lung Tumors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC): Results from the PROMISE 006 Trial Thoracic Quad Shot RT in Stage IV NSCLC.
Journal: International journal of radiation oncology, biology, physics
Published: April 01, 2026
Brain Metastases in Diffuse Pleural Mesothelioma: Clinical, Histologic, and Molecular Correlates.
Journal: JTO clinical and research reports
Published: September 30, 2025
Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer.
Journal: JCO precision oncology
Published: June 29, 2023
Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 10, 2022
A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma.
Journal: JTO clinical and research reports
Published: September 14, 2022
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.
Journal: Nature medicine
Published: February 15, 2022
Pilot Study of Dacomitinib for Patients With Metastatic EGFR-Mutant Lung Cancers With Disease Progression After Initial Treatment With Osimertinib.
Journal: JCO precision oncology
Published: January 04, 2021
Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor.
Journal: JCO precision oncology
Published: August 07, 2020
A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 27, 2019
Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer.
Journal: Clinical lung cancer
Published: July 04, 2016
Last Updated: 09/26/2026